ZIMIPIME-500
MRP: 2,500
Packaging: 500 MG
Pack Type: injection
Composition:
Cefepime 500mg
Indication:
Bacteremia & Septicemia Meningitis Pneumonia & Bronchitis Skin & Soft Tissue Infection Urinary Tract Infection Post Surgical Condition
Description:
Cefepime 500mg Injection**
Cefepime 500mg is a fourth-generation cephalosporin antibiotic designed to treat a wide range of serious bacterial infections, including those caused by multidrug-resistant gram-negative and gram-positive organisms. It is particularly effective against Pseudomonas aeruginosa, Enterobacteriaceae, and Streptococcus species.
Administered via intravenous (IV) or intramuscular (IM) routes, Cefepime is typically used in hospital or clinical settings for treating infections such as pneumonia, urinary tract infections (UTIs), intra-abdominal infections, and febrile neutropenia.
Tags:
- Broad-spectrum activity against gram-positive and gram-negative bacteria
- Effective against multi-drug-resistant pathogens
- Used in life-threatening and hospital-acquired infections
- Strong efficacy in treating Pseudomonas and Enterobacter species
- Rapid action when given parenterally (IV/IM)
Usage Information
Dosage
Adults: Typically 500mg to 2g every 8–12 hours depending on the severity and type of infection Children: Dosage based on body weight and medical condition Administer via IV or deep IM injection Adjust dosage in patients with renal impairment Should be reconstituted with sterile water for injection before use
Side Effects
Pain, redness, or swelling at injection site Nausea, vomiting Diarrhea Rash or itching Headache Rarely: confusion, seizures (especially in renal impairment)
Contraindications
Hypersensitivity to cefepime or other cephalosporins History of severe allergic reaction to penicillins Use with caution in patients with renal dysfunction Not recommended in neonates without professional evaluation Avoid in patients with CNS disorders unless closely monitored